Elucidating the Pathogenic Mechanisms of VPS35 Mutations in Parkinson's Disease

阐明帕金森病 VPS35 突变的致病机制

• 批准号: 8620854
• 负责人: Xinglong Wang
• 金额: $ 19.81万
• 依托单位: CASE WESTERN RESERVE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2013
• 资助国家: 美国
• 起止时间: 2013-09-01 至 2015-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8620854
• 关键词: Address; Affect; Brain; Cell membrane; Cell physiology; Communication; Complex; Dementia; Disease; Disease model; Dominant Genes; Endosomes; Equilibrium; Event; Genes; Golgi Apparatus; Hippocampus (Brain); Human; In Vitro; Investigation; Lead; Mediating; Midbrain structure; Mitochondria; Mutation; Nerve Degeneration; Neuronal Dysfunction; Neurons; Organelles; Outcome; Parkinson Disease; Pathogenesis; Physiological; Play; Proteins; Quality Control; Recycling; Regulation; Role; Signal Pathway; Signal Transduction; Site; Sorting - Cell Movement; Substantia nigra structure; Synapses; System; Therapeutic Intervention; Time; Vesicle; base; dopaminergic neuron; in vivo; insight; mitochondrial dysfunction; mutant; neuroblastoma cell; new therapeutic target; novel; overexpression; public health relevance; trafficking

PROJECT SUMMARY Mitochondrial dysfunction plays a prominent role in the pathogenesis of Parkinson's disease (PD). Mitochondria are dynamics organelles that undergo continual fission and fusion events which serve crucial physiological function. Increasing evidence demonstrated abnormal mitochondrial dynamics in PD and PD models, suggesting that an altered balance in mitochondrial fission/fusion and impaired mitochondrial quality control was likely a common mechanism leading to mitochondrial and neuronal dysfunction/degeneration critical to the pathogenesis of PD. Mutations in VPS35 cause autosomal dominant PD. VPS35 is a key component of the retromer complex, which is be important for endosome-to-golgi and endosome-to-plasma membrane sorting and many signaling events. Recent studies found the localization of VPS35 on mitochondria and its involvement in inter-organelle communication between mitochondria and other organelles. In our preliminary studies, we confirmed the mitochondrial localization of VPS35 in both human neuroblastoma cells and human brain hippocampal neurons. We further found that overexpression of wild-type VPS35 in neurons caused significant changes of mitochondrial dynamics, which became more severe in neurons expressing PD- associated VPS35 mutant D620N. More importantly, we found that VPS35 physically interacted with DLP1, a key regulator of mitochondrial dynamics, which was enhanced by PD-associated mutation. All these exciting findings strongly suggest that VPS35 were involved in the regulation of mitochondrial dynamics which may be impaired by VPS35 PD associated mutations and detailed investigation into the potential role of PS1 in mitochondrial function and dynamics is warranted. Our proposed study will be the first mechanistic study investigating the effect of the pathogenic VPS35 PD mutations on mitochondrial dynamics/function and neuronal function and will likely reveal a novel role of VPS35 in the regulation of mitochondrial dynamics/function. In addition, our proposed studies will also provide novel insights into the contribution of retromer to various cellular processes and signaling pathways.

项目摘要 线粒体功能障碍在帕金森病（PD）的发病机制中起着重要作用。 线粒体是动态细胞器，其经历持续的裂变和融合事件， 生理功能越来越多的证据表明PD和PD患者的线粒体动力学异常 模型，表明线粒体分裂/融合平衡的改变和线粒体质量的受损 控制可能是导致线粒体和神经元功能障碍/变性的常见机制 对PD的发病机制至关重要。VPS 35突变导致常染色体显性PD。VPS 35是一把钥匙 retromer复合物的组分，其对于内体到高尔基体和内体到血浆是重要的 膜分选和许多信号事件。最近的研究发现VPS 35定位于线粒体上， 以及其参与线粒体和其他细胞器之间的细胞器间通讯。在我们 初步研究，我们证实了VPS 35在两种人神经母细胞瘤细胞中的线粒体定位 和人脑海马神经元。我们进一步发现野生型VPS 35在神经元中的过度表达， 引起线粒体动力学的显著变化，在表达PD-1的神经元中变得更加严重。 相关的VPS 35突变体D 620 N。更重要的是，我们发现VPS 35与DLP 1发生了物理相互作用， 线粒体动力学的关键调节因子，这是由PD相关突变增强。所有这些令人兴奋 研究结果强烈表明，VPS 35参与了线粒体动力学的调节， 与VPS 35 PD相关的突变损害，并详细研究了PS1在 线粒体功能和动力学是有保证的。我们提出的研究将是第一个机制研究 研究致病性VPS 35 PD突变对线粒体动力学/功能的影响， 神经元功能，并可能揭示VPS 35在调节线粒体功能中的新作用。 动力学/功能此外，我们提出的研究也将提供新的见解， 逆转录酶参与各种细胞过程和信号传导途径。